Earnings Feed
Start Free
HARTFORD INSURANCE GROUP, INC.·4

Feb 26, 4:06 PM ET

Swift Christopher 4

4 · HARTFORD INSURANCE GROUP, INC. · Filed Feb 26, 2026

Research Summary

AI-generated summary of this filing

Updated

HIG CEO Christopher Swift Receives 102,382 Share Award

What Happened

  • Christopher Swift, Chairman, CEO and a director of Hartford Insurance Group (HIG), was granted a derivative award of 102,382 units on 2026-02-24. The award was recorded at $0.00 (no cash paid on grant). This is an equity award (derivative), not an open-market purchase or sale.

Key Details

  • Transaction date: 2026-02-24; filing date: 2026-02-26 (filed within the Form 4 reporting window).
  • Transaction type/code: A (Grant, award or other acquisition) of derivative securities; reported acquisition price $0.00.
  • Amount: 102,382 derivative units (shares/units underlying equity award).
  • Vesting/ exercisability: Footnote F1 indicates one‑third vests/exercises on 2027-02-24, another one‑third on 2028-02-24, and the final one‑third on 2029-02-24 (third anniversary of grant).
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Filing timeliness: Appears timely (filed two days after the transaction).

Context

  • This was a grant of derivative equity (likely options or restricted units) rather than a cash purchase or a sale — no immediate cash changed hands. Derivative awards typically convert to common shares or become exercisable only after vesting; consult the full Form 4 or company proxy for exact award type and tax/withholding terms.
  • Grants are routine for executive compensation and do not by themselves indicate buying or selling sentiment; they represent future compensation tied to continued service or performance.

Insider Transaction Report

Form 4
Period: 2026-02-24
HARTFORD INSURANCE GROUP, INC.HIG
Swift Christopher
DirectorChairman and CEO
Transactions
  • Award

    Stock Option

    [F1]
    2026-02-24+102,382→ 102,382 total
    Exercise: $140.54Exp: 2036-02-24→ Common Stock (102,382 underlying)
Holdings

  • Common Stock

    261,560.485

  • Common Stock

    (indirect: By Spouse)
    40,003

  • Common Stock

    (indirect: By Trust)
    95,386

  • Common Stock

    (indirect: By Trust)
    60,865

  • Stock Option

    [F2]
    Exercise: $49.01Exp: 2029-02-26→ Common Stock (352,263 underlying)
    352,263

  • Stock Option

    [F3]
    Exercise: $51.87Exp: 2031-02-23→ Common Stock (310,820 underlying)
    310,820

  • Stock Option

    [F4]
    Exercise: $53.81Exp: 2028-02-27→ Common Stock (284,819 underlying)
    284,819

  • Stock Option

    [F5]
    Exercise: $55.27Exp: 2030-02-25→ Common Stock (327,679 underlying)
    327,679

  • Stock Option

    [F6]
    Exercise: $69.41Exp: 2032-02-23→ Common Stock (301,932 underlying)
    301,932

  • Stock Option

    [F7]
    Exercise: $78.28Exp: 2033-02-28→ Common Stock (248,933 underlying)
    248,933

  • Stock Option

    [F8]
    Exercise: $95.74Exp: 2034-02-27→ Common Stock (116,414 underlying)
    116,414

  • Stock Option

    [F9]
    Exercise: $116.41Exp: 2035-02-25→ Common Stock (99,403 underlying)
    99,403
Footnotes (9)
  • [F1]One-third of the options will become exercisable on February 24, 2027, an additional one-third of the options will become exercisable on February 24, 2028 and the remaining one-third of the options will become exercisable on February 24, 2029, the third anniversary of the grant date.
  • [F2]The options became fully exercisable on February 26, 2022, the third anniversary of the grant date.
  • [F3]The options became fully exercisable on February 23, 2024, the third anniversary of the grant date.
  • [F4]The options became fully exercisable on February 27, 2021, the third anniversary of the grant date.
  • [F5]The options became fully exercisable on February 25, 2023, the third anniversary of the grant date.
  • [F6]The options became fully exercisable on February 23, 2025, the third anniversary of the grant date.
  • [F7]One-third of the options became exercisable on February 28, 2024, an additional one-third of the options became exercisable on February 28, 2025 and the remaining one-third of the options will become exercisable on February 28, 2026, the third anniversary of the grant date.
  • [F8]One-third of the options became exercisable on February 27, 2025, an additional one-third of the options will become exercisable on February 27, 2026 and the remaining one-third of the options will become exercisable on February 27, 2027, the third anniversary of the grant date.
  • [F9]One-third of the options became exercisable on February 25, 2026, an additional one-third of the options will become exercisable on February 25, 2027 and the remaining one-third of the options will become exercisable on February 25, 2028, the third anniversary of the grant date.
Signature
Anthony J. Salerno, Jr., Attorney-in-Fact|2026-02-26

Documents

1 file
  • 4
    doc4.xmlPrimary